Your browser doesn't support javascript.
loading
Juego patológico e hipersexualidad debidos a tratamiento dopaminérgico en la enfermedad de Parkinson / Pathological gambling and hypersexuality due to dopaminergic treatment in Parkinson’s disease
Martín Fernández, F; Martín González, T.
Affiliation
  • Martín Fernández, F; Hospital Universitario de Getafe. Getafe. España
  • Martín González, T; Hospital Universitario de Getafe. Getafe. España
Actas esp. psiquiatr ; 37(2): 118-122, mar.-abr. 2009. tab
Article in Spanish | IBECS | ID: ibc-61849
Responsible library: ES1.1
Localization: BNCS
RESUMEN
Introducción. La prevalencia de trastornos psiquiátricos en pacientes con enfermedad de Parkinson varía de un 12 a un 90 %. La depresión es el trastorno más frecuente en la evolución natural de la enfermedad de Parkinson; mientras que las alteraciones psicóticas e hipomaníacas se relacionan con el tratamiento con L-dopa y agonistas dopaminérgicos. Otras patologías psiquiátricas reconocidas, aunque menos frecuentes, son la hipersexualidad y el desarrollo de determinadas conductas adictivas juego patológico y sobredosificación de fármacos antiparkinsonianos. Caso clínico. Se presenta el caso de un paciente varón diagnosticado de enfermedad de Parkinson a una edad temprana, tratado con L-dopa y distintos agonistas dopaminérgicos en combinación, que a lo largo de su evolución ha presentado hipersexualidad y conductas de juego patológico no relacionadas con alteraciones psicóticas ni del estado de ánimo. Conclusiones. Fueron necesarios varios ingresos hospitalarios para reconocer una pauta de consumo abusivo de L-dopacomo factor precipitante de las alteraciones conductuales. La presencia de conductas patológicas de juego y/o hipersexualidad, sin sintomatología psicótica ni afectiva concomitante, en un varón con enfermedad de Parkinson de inicio temprano, que realiza tratamiento con L-dopa y agonistas dopaminérgicos y presenta fluctuaciones motoras y discinesias debería alertar sobre la posibilidad de sobredosificación de estos fármacos. Reconocer precozmente la presencia de estas alteraciones, englobadas en lo que se describe como ®síndrome de desregulación dopaminérgica», permitiría una intervención temprana sobre la causa que lo provoca y evitaría las complicaciones tanto médicas como sociales que ocasiona (AU)
ABSTRACT
Introduction. Prevalence of psychiatric disorders in patients suffering from Parkinson’s disease varies from 12 to 90%. The most common disorder in the natural evolution of Parkinson’s disease is depression. However, episodes of psychosis and hypomania are related to treatment with L-dopa and dopaminergic agents. Other recognized, although less frequent, psychiatric disorders are hypersexuality and development of certain addictive behaviors, which is compulsive gambling and overdosing of anti-Parkinson agents. Clinical case. A case is presented of a male patient diagnosed with Parkinson’s Disease at an early age who was treated with L-dopa and a combination of dopaminergic agents. During the course of his evolution he manifested symptoms of hypersexuality and pathological gambling which were unrelated to psychotic or mood changes. Conclusions. A number of hospital admissions were needed into order to detect a pattern of abusive consumption of L-dopa as the main factor behind his behavior changes. The possibility of over dosage of L-dopa and dopaminergic drugs should be considered when there is pathological gambling conduct and/or hypersexuality, without psychotic or accompanying affective symptoms, in a male who develops Parkinson’s disease at an early age and who undergoes treatment with these drugs and manifests motor fluctuations and dyskinesias. Early detection of the presence of these alterations, included within those described as ®dopaminergic dysregulation syndrome», would allow for an early intervention on the cause behind them and would hence avoid the possible medical and social complications (AU)
Subject(s)
Search on Google
Collection: National databases / Spain Health context: SDG3 - Health and Well-Being Health problem: Target 3.5: Prevention and treatment of consumption of psychoactive substances Database: IBECS Main subject: Parkinson Disease / Levodopa / Dyskinesias / Erectile Dysfunction / Mental Disorders Type of study: Diagnostic study / Risk factors / Screening study Limits: Humans / Male Language: Spanish Journal: Actas esp. psiquiatr Year: 2009 Document type: Article Institution/Affiliation country: Hospital Universitario de Getafe/España
Search on Google
Collection: National databases / Spain Health context: SDG3 - Health and Well-Being Health problem: Target 3.5: Prevention and treatment of consumption of psychoactive substances Database: IBECS Main subject: Parkinson Disease / Levodopa / Dyskinesias / Erectile Dysfunction / Mental Disorders Type of study: Diagnostic study / Risk factors / Screening study Limits: Humans / Male Language: Spanish Journal: Actas esp. psiquiatr Year: 2009 Document type: Article Institution/Affiliation country: Hospital Universitario de Getafe/España
...